Slate offers another article about how treating clinical drug trial data as trade secrets is bad. The big problem with this being that the good results get made public when the drug is approved, but when it is tested for different uses and does not gain approval, we never officially know why, even when the “why” is something along the lines of “this drug dramatically increases suicidal tendancies in otherwise healthy adults.” An older article says that drug companies do shodd research, and of course I’ve already blogged about the general suckiness of the FDA, which is putting the companies it works with before the good of the public.